William Leigh Ledger

William Leigh Ledger

Auto-generated profile, based on publicly available information

William Leigh Ledger

University of New South Wales, Sydney

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
CCC. Coughlan
C. Coughlan
WLW. Ledger
W. Ledger
QWQ. Wang
Q. Wang
FLFenghua Liu
Fenghua Liu
ADAygul Demirol
Aygul Demirol
TLTin-chiu Li
Tin-chiu Li

1 February 1998 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
JSJack D. Sobel
Jack D. Sobel
SFSabastian Faro
Sabastian Faro
RFRex W. Force
Rex W. Force
BFBetsy Foxman
Betsy Foxman
WLWilliam J. Ledger
William J. Ledger
PSPaul R. Summers
Paul R. Summers

1 October 1995 in Human Reproduction
Verified
Journal Article
Closed access
PDF file
ACA.M. Clark
A.M. Clark
WLW. Ledger
W. Ledger
CGC. Galletly
C. Galletly
LTL. Tomlinson
L. Tomlinson
FBF. Blaney
F. Blaney
RNR.J. Norman
R.J. Norman
Obesity can affect ovulation and the chances of pregnancy. In this prospective study, a weight loss programme was assessed to determine whether it could help infertile overweight anovulatory women to establish ovulation and assist in achieving pregnancy, ideally without further medical intervention. The subjects acted as their own historical controls. They underwent a weekly programme of behavioural change in relation to exercise and diet over 6months; those who did not complete the 6 months were treated as the comparison group. Women in the study group lost an average of 6.3 kg, with 12 of the 13 subjects resuming ovulation and 11 becoming pregnant, five of these spontaneously. Fitness, diet and psychometric measurements all improved. Fasting insulin and testosterone concentrations dropped significantly, while sex hormone binding globulin concentrations rose. None of these changes occurred in the comparison group. Thus, weight loss with a resultant improvement in ovulation, pregnancy outcome,self-esteem and endocrine parameters is the first therapeutic option for women who are infertile and overweight.

15 January 2002 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
SWSteven S. Witkin
Steven S. Witkin
SGStefan Gerber
Stefan Gerber
WLWilliam J. Ledger
William J. Ledger
Interleukin-1 receptor antagonist (IL-1RA) is a naturally occurring competitive inhibitor of interleukin-1 (IL-1)–induced proinflammatory activity. T

28 September 2007 in Human Reproduction Update
Verified
Journal Article
Open access
PDF file
GJG.L. Jones
G.L. Jones
JHJenny Hall
Jenny Hall
ABA.H. Balen
A.H. Balen
WLW.L. Ledger
W.L. Ledger
The symptoms typically associated with polycystic ovary syndrome (PCOS) such as acne, hirsutism, irregular menses, amenorrhoea, obesity and subfertility are a major source of psychological morbidity and can negatively affect quality of life (QoL). We systematically searched the literature to identify the impact of symptoms and treatments for PCOS on health-related QoL (HRQoL) and to report on the types and psychometric properties of the instruments used. Papers were retrieved by systematically searching four electronic databases and hand searching relevant reference lists and bibliographies. Nineteen papers used a standardized questionnaire to measure health status; of these 12 (63.2%) used generic tools and 8 (42%) used the disease-specific PCOS questionnaire. Although a meta-analysis was not possible, it appears that weight concerns have a particular negative impact upon HRQoL, although the role of body mass index in affecting HRQoL scores is inconclusive from the available evidence. Acne is the area least reported upon in terms of its impact upon HRQoL. With the exception of three studies, most of the research has focused upon adult women with PCOS. Despite the benefits of HRQoL measures in research, few are being used to evaluate the outcomes of treatment for PCOS upon the subjective health status of women with the condition.

15 October 2008 in Human Reproduction Update
Verified
Journal Article
Open access
PDF file
AWA.L. Waylen
A.L. Waylen
MMM. Metwally
M. Metwally
GJG.L. Jones
G.L. Jones
AWA.J. Wilkinson
A.J. Wilkinson
WLW.L. Ledger
W.L. Ledger
The aim of this meta-analysis was to investigate whether any difference exists in success rate of clinical outcomes of assisted reproductive technologies (ART) between women who actively smoke cigarettes at the time of treatment and those who do not. An intensive computerized search was conducted on published literature from eight databases, using search terms related to smoking, assisted reproduction and outcome measures. Eligible studies compared outcomes of ART between cigarette smoking patients and a control group of non-smoking patients and reported on live birth rate per cycle, clinical pregnancy rate per cycle, ectopic pregnancy rate per pregnancy or spontaneous miscarriage rate per pregnancy, and 21 studies were included in the meta-analyses. Pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated for the data, and statistical heterogeneity was tested for using χ2 and I2 values. A systematic review examined the effect of smoking upon fertilization rates across 17 studies. Smoking patients demonstrated significantly lower odds of live birth per cycle (OR 0.54, 95% CI 0.30–0.99), significantly lower odds of clinical pregnancy per cycle (OR 0.56, 95% CI 0.43–0.73), significantly higher odds of spontaneous miscarriage (OR 2.65, 95% CI 1.33–5.30) and significantly higher odds of ectopic pregnancy (OR 15.69, 95% CI 2.87–85.76). A systematic literature review revealed that fertilization rates were not significantly different between smoking and non-smoking groups in most studies. This meta-analysis provides compelling evidence for a significant negative effect of cigarette smoking upon clinical outcomes of ART and should be presented to infertility patients who smoke cigarettes in order to optimize success rates.